PI(16:0/20:3(5Z,8Z,11Z))

Metabolite details

Identifier

QQCJRPYWJFBHNN-DAXZNSEHSA-N

InChI Key

QQCJRPYWJFBHNN-DAXZNSEHSA-N

IUPAC name

Preferred name

PI(16:0/20:3(5Z,8Z,11Z))

INN name

—

Synonym

[(2R)-3-(hexadecanoyloxy)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

ChEBI

CHEBI:88391

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• non_COVID_19_healthy_vs_non_critical_COVID_19
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_vs_Palmitate
• Control_vs_Palmitate
• G1_Ctrl_vs_G2_Ab
• BSA_Control_vs_AA